Raymond James & Associates Aqua Bounty Technologies, Inc. Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$1.34 - $2.26 $85,504 - $144,208	-63,809 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$2.1 - $4.36 $103,028 - $213,905	-49,061 Reduced 43.47%	63,809 $134,000
Q3 2021 Nov 02, 2021	SELL	$3.9 - $5.67 $37,732 - $54,857	-9,675 Reduced 7.9%	112,870 $459,000
Q2 2021 Aug 11, 2021	SELL	$4.85 - $6.9 $58,360 - $83,027	-12,033 Reduced 8.94%	122,545 $657,000
Q1 2021 May 14, 2021	BUY	$6.09 - $12.2 $14,890 - $29,829	2,445 Added 1.85%	134,578 $902,000
Q4 2020 Feb 12, 2021	BUY	$3.56 - $10.21 $15,058 - $43,188	4,230 Added 3.31%	132,133 $1.16 Million
Q3 2020 Nov 04, 2020	BUY	$2.49 - $5.16 $318,478 - $659,979	127,903 New	127,903 $573,000

5.32M

Ticker AQB
Exchange NASDAQ
Sector Consumer Defensive
Industry Farm Products
Shares Outstandng 71,110,704
Market Cap $49.1M
Description
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.